Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia

Chemico-Biological Interactions

Volumn 150, Issue 2, 2004, Pages 179-187

  Campbell, Scott D ^a   De Morais, Sonia M ^a   Xu, Jinghai J ^a  

^a PFIZER INC   (United States)

Author keywords

Bilirubin; Drug interactions; Hyperbilirubinemia; Jaundice; OATP; Organic anion transporting polypeptide

Indexed keywords

BILIRUBIN; CYCLOSPORIN A; INDINAVIR; ORGANIC ANION TRANSPORTER; RIFAMYCIN; SAQUINAVIR;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENCY; EMBRYO; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERBILIRUBINEMIA; IN VITRO STUDY; KIDNEY;

BILIRUBIN; CELL LINE; HUMANS; HYPERBILIRUBINEMIA; KIDNEY; KINETICS; LIVER; ORGANIC ANION TRANSPORT POLYPEPTIDE C;

EID: 7744241812     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2004.08.008     Document Type: Article

References (46)

1. H.J. Zimmerman Drug-induced liver disease Clin. Liver Dis. 4 2000 73 96
2. S.D. Zucker, X. Qin, S.D. Rouster, F. Yu, R.M. Green, P. Keshavan, J. Feinberg, and K.E. Sherman Mechanism of indinavir-induced hyperbilirubinemia Proc. Natl. Acad. Sci. USA 98 2001 12671 12676
3. A. Laupacis, P.A. Keown, R.A. Ulan, N.R. Sinclair, and C.R. Stiller Hyperbilirubinaemia and cyclosporin A levels Lancet 2 1981 1426 1427
4. R. Loertscher, M. Wenk, F. Harder, F. Brunner, F. Follath, and G. Thiel Hyperbilirubinaemia and cyclosporin A levels in renal transplant patients Lancet 2 1981 635 636
5. G. Acocella, F.B. Nicolis, and L.T. Tenconi The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man Gastroenterology 49 1965 521 525
6. T. Kamisako, Y. Kobayashi, K. Takeuchi, T. Ishihara, K. Higuchi, Y. Tanaka, E.C. Gabazza, and Y. Adachi Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance J. Gastroenterol. 35 2000 659 664
7. D. Keppler, and J. Konig Hepatic secretion of conjugated drugs and endogenous substances Semin. Liver Dis. 20 2000 265 272
8. D. Keppler, Y. Cui, J. Konig, I. Leier, and A. Nies Export pumps for anionic conjugates encoded by MRP genes Adv. Enzyme Regul. 39 1999 237 246
9. B. Hagenbuch, and P.J. Meier Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties Pflügers Arch.-Eur. J. Physiol. 447 2003 653 665
10. Y. Cui, J. Konig, I. Leier, U. Buchholz, and D. Keppler Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6 J. Biol. Chem. 276 2001 9626 9630
11. O. Briz, M.A. Serrano, R.I. MacIas, J. Gonzalez-Gallego, and J.J. Marin Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin Biochem. J. 371 2003 897 905
12. J. Konig, Y. Cui, A.T. Nies, and D. Keppler A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane Am. J. Physiol. Gastrointest. Liver Physiol. 278 2000 G156 G164
13. W.Y. Chen, E.C. Bailey, S.L. McCune, J.Y. Dong, and T.M. Townes Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase Proc. Natl. Acad. Sci. USA 94 1997 5798 5803
14. S.B. Amin, C. Ahlfors, M.S. Orlando, L.E. Dalzell, K.S. Merle, and R. Guillet Bilirubin and serial auditory brainstem responses in premature infants Pediatrics 107 2001 664 670
15. G. Lockitch, A.C. Halstead, S. Albersheim, C. MacCallum, and G. Quigley Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer Clin. Chem. 34 1988 1622 1625
16. H. Kusuhara, and Y. Sugiyama Drug-drug interactions involving the membrane transport process A.D. Rodrigues Drug-Drug Interactions 2002 Marcel Dekker, Inc. New York 123 188
17. R.G. Tirona, B.F. Leake, A.W. Wolkoff, and R.B. Kim Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation J. Pharmacol. Exp. Ther. 304 2003 223 228
18. T.N. Kakuda, K.A. Struble, and S.C. Piscitelli Protease inhibitors for the treatment of human immunodeficiency virus infection Am. J. Health-Syst. Pharm. 55 1998 233 254 erratum appears in Am. J. Health Syst. Pharm. 1998 Apr 15;55(8):847
19. C.L. Cooper, M.A. Parbhakar, and J.B. Angel Hepatotoxicity associated with antiretroviral therapy containing dual versus single protease inhibitors in individuals coinfected with hepatitis C virus and human immunodeficiency virus Clin. Infect. Dis. 34 2002 1259 1263
20. Y. Cui, and B. Walter Influence of albumin binding on the substrate transport mediated by human hepatocyte transporters OATP2 and OATP8 J. Gastroenterol. 38 2003 60 68
21. P. Wang, R.B. Kim, J.R. Chowdhury, and A.W. Wolkoff The human organic anion transport protein SLC21A6 is not sufficient for bilirubin transport J. Biol. Chem. 278 2003 20695 20699
22. M.G. Mediavilla, L. Pascolo, J.V. Rodriguez, E.E. Guibert, J.D. Ostrow, and C. Tiribelli Uptake of [(3)H]bilirubin in freshly isolated rat hepatocytes: role of free bilirubin concentration FEBS Lett. 463 1999 143 145
23. H.J. Zimmerman Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals of the Liver first ed. 1978 Prentice Hall
24. C. Nouts, M. Bonarek, P. Morlat, I. Delevaux, F. Bonnet, D. Lacoste, N. Bernard, and J. Beylot The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir Int. J. STD AIDS 12 2001 29 33
25. C.R. Rayner, L.D. Esch, H.E. Wynn, and R. Eales Symptomatic hyperbilirubinemia with indinavir/ritonavir-containing regimen Ann. Pharmacother. 35 2001 1391 1395
26. T. Cantz, A.T. Nies, M. Brom, A.F. Hofmann, and D. Keppler MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells Am. J. Physiol.-Gastrointest. Liver Physiol. 278 2000 522 531
27. A. Treiber, R. Schneiter, S. Delahaye, and M. Clozel Inhibition of organic anion transporting polypeptide-mediated hepatic uptake is the major determinant in the pharmacokinetic interaction between bosentan and cyclosporin A in the rat J. Pharmacol. Exp. Ther. 308 2004 1121 1129
28. Y. Shitara, T. Itoh, H. Sato, A.P. Li, and Y. Sugiyama Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A J. Pharmacol. Exp. Ther. 304 2003 610 616
29. D.K. Meijer, and J.E. van Monffoort Interactions of cationic drugs and cardiac glycosides at the hepatic uptake level: studies in the rat in vivo, isolated perfused rat liver, isolated rat hepatocytes and oocytes expressing oatp2 Arch. Pharm. Res. 25 2002 397 415
30. T. Kodawara, S. Masuda, H. Wakasugi, Y. Uwai, T. Futami, H. Saito, T. Abe, and K. Inu Organic anion transporter oatp2-mediated interaction between digoxin and amiodarone in the rat liver Pharm. Res. 19 2002 738 743
31. S.R. Vavricka, J. Van Montfoort, H.R. Ha, P.J. Meier, and K. Fattinger Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver Hepatology 36 2002 164 172
32. G.K. Dresser, D.G. Bailey, B.F. Leake, U.I. Schwarz, P.A. Dawson, D.J. Freeman, and R.B. Kim Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine Clin. Pharmacol. Ther. 71 2002 11 20
33. U. Eckhardt, J.A. Horz, E. Petzinger, W. Stuber, M. Reers, G. Dickneite, H. Daniel, M. Wagener, B. Hagenbuch, B. Stieger, and P.J. Meier The peptide-based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat liver organic anion-transporting polypeptide Hepatology 24 1996 380 384
34. H. Ishizuka, K. Konno, H. Naganuma, K. Nishimura, H. Kouzuki, H. Suzuki, B. Stieger, P.J. Meier, and Y. Sugiyama Transport of temocaprilat into rat hepatocytes: role of organic anion transporting polypeptide J. Pharmacol. Exp. Ther. 287 1998 37 42
35. B. Hsiang, Y. Zhu, Z. Wang, Y. Wu, V. Sasseville, W.P. Yang, and T.G. Kirchgessner A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters J. Biol. Chem. 274 1999 37161 37168
36. D. Nakai, R. Nakagomi, Y. Furuta, T. Tokui, T. Abe, T. Ikeda, and K. Nishimura Human liver-specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes J. Pharmacol. Exp. Ther. 297 2001 861 867
37. M. Sasaki, H. Suzuki, K. Ito, T. Abe, and Y. Sugiyama Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2(MRP2/ABCC2) J. Biol. Chem. 277 2002 6497 6503
38. F. Baldini, S. Di Giambenedetto, A. Cingolani, R. Murri, A. Ammassari, and A. De Luca Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study AIDS 14 2000 1660 1662
39. C. Michalski, Y. Cui, A.T. Nies, A.K. Nuessler, P. Neuhaus, U.M. Zanger, K. Klein, M. Eichelbaum, D. Keppler, and J. Konig A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter J. Biol. Chem. 277 2002 43058 43063
40. R.G. Tirona, B.F. Leake, G. Merino, and R.B. Kim Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans J. Biol. Chem. 276 2001 35669 35675
41. I. Tamai, J. Nezu, H. Uchino, Y. Sai, A. Oku, M. Shimane, and A. Tsuji Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family Biochem. Biophys. Res. Commun. 273 2000 251 260
42. T. Nozawa, M. Nakajima, I. Tamai, K. Noda, J. Nezu, Y. Sai, A. Tsuji, and T. Yokoi Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis J. Pharmacol. Exp. Ther. 302 2002 804 813
43. J.F. Martin, J.M. Vierling, A.W. Wolkoff, B.F. Scharschmidt, J. Vergalla, J.G. Waggoner, and P.D. Berk Abnormal hepatic transport of indocyanine green in Gilbert's syndrome Gastroenterology 70 1976 385 391
44. M. Persico, E. Persico, C.T. Bakker, I. Rigato, A. Amoroso, R. Torella, P.J. Bosma, C. Tiribelli, and J.D. Ostrow Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1 Hepatology 33 2001 627 632
45. S. Gentile, M. Persico, G. Baldini, G. Lunazzi, C. Tiribelli, and G.L. Sottocasa The implication of bilitranslocase function in the impaired rifamycin SV metabolism in Gilbert's syndrome Clin. Sci. 68 1985 675 680
46. S. Gentile, R. Marmo, M. Persico, P. Bronzino, and M. Coltorti Impaired plasma clearance of nicotinic acid and rifamycin-SV in Gilbert's syndrome: evidence of a functional heterogeneity Hepato-Gastroenterology 32 1985 113 116